
|Videos|July 15, 2021
Incorporating Esketamine into Practice for Treatment-Resistant Depression
Advertisement
Episodes in this series

Requirements that healthcare clinics must satisfy to become a certified treatment center permitted to administer intranasal esketamine to patients with treatment-resistant depression.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive FDA Meeting for Abuse Deterrent Fentanyl Patch
2
Candy and Other Food Treats or Tricks
3
Trick or Treat: Fiddling While Rome Burns or Playing a Violin of Hope?
4
“Porosity”: Connecting 2 Western Cultural Psychiatric Discourses in Tokyo by Way of Naples
5











